BULLISHWHALES
BullishWhales · Congress · Issuer Profile
NASDAQ: HALOHalozyme Therapeutics Inc
HealthcareMkt Cap $8.28BCongress ownership rank #1406

Halozyme Therapeutics Inc Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 12 trades in Halozyme Therapeutics Inc (NASDAQ: HALO) since 2017, across 4 members, worth an estimated $1.6M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 5 buys against 7 sells, a modestly sell-led skew, with Democratic members responsible for 100% of the trades and Republican members 0%. The most recent disclosure shown was filed April 2026, and Gilbert Cisneros has filed the most HALO transactions among those shown, with 2. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Halozyme Therapeutics Inc (HALO) stock overview and the complete trade table below.

Data updated

Trades
2
Politicians
1
Filings
1
Disclosed Vol
$16.00K
Buys
2
100%
Sells
0
0%

Price & congressional trade timeline

Party breakdown

Halozyme Therapeutics congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturn
Apr 7, 2026Mar 9, 202629 daysBUY
$1,001 - $15,000
+2.47%
Apr 7, 2026Mar 9, 202629 daysBUY
$1,001 - $15,000
+2.47%
Go to

Halozyme Therapeutics (HALO) congressional trading FAQ

Can members of Congress legally trade Halozyme Therapeutics (HALO) stock?

Yes. Members of Congress are permitted to trade individual stocks, including Halozyme Therapeutics (HALO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.

Are congressional Halozyme Therapeutics (HALO) trades public?

Yes. Every congressional trade in Halozyme Therapeutics (HALO) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded Halozyme Therapeutics (HALO)?

Members of Congress have disclosed 12 trades in Halozyme Therapeutics (HALO) worth $1.6M across 4 members, according to public STOCK Act filings.

Which members of Congress have traded Halozyme Therapeutics (HALO)?

Recent and active filers of Halozyme Therapeutics (HALO) disclosures include Gilbert Cisneros. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade Halozyme Therapeutics (HALO) more?

Across disclosed Halozyme Therapeutics (HALO) trades, 100% were by Democrats and 0% by Republicans, led by Democrats (100%).

What is the most recent congressional Halozyme Therapeutics (HALO) trade?

The most recent disclosed Halozyme Therapeutics (HALO) trade was a purchase by Gilbert Cisneros, filed Apr 6, 2026.

Browse all stocks Congress tradesCongressional trading overviewHalozyme Therapeutics (HALO) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30